KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3p-Reference-Cited by-同舟云学术

KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3p

Published:2019-07-22 Issue:6 Volume:37 Page:424-431
ISSN:0263-6484
Container-title:Cell Biochemistry and Function
language:en
Short-container-title:Cell Biochem Funct

Author:

Gan Huizhu¹,Lin Lin²,Hu Nanjun¹,Yang Yang¹,Gao Yu¹,Pei Yu¹,Chen Kang¹,Sun Butong¹^ORCID

Affiliation:

1. Department of OncologyChina‐Japan Union Hospital of Jilin University Changchun China

2. National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

Natural Science Foundation of Jilin Province

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbf.3420

Reference28 articles.

1. Global cancer statistics

2. Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

3. Current Status of Immunotherapy for Non-Small-Cell Lung Cancer

4. Chromosome movement: Dynein-out at the kinetochore

5. Global and local control of microtubule destabilization promoted by a catastrophe kinesin MCAK/XKCM1

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA‑325: A comprehensive exploration of its multifaceted roles in cancer pathogenesis and therapeutic implications (Review);Oncology Letters;2024-07-26

2. Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer;BMC Cancer;2024-06-01

3. KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker;Critical Reviews in Clinical Laboratory Sciences;2024-02-12

4. KIF2C: An important factor involved in signaling pathways, immune infiltration, and DNA damage repair in tumorigenesis;Biomedicine & Pharmacotherapy;2024-02

5. XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer;PeerJ;2024-01-16